Compare Ginkgo Bioworks Holdings Inc (DNA) vs iShares MSCI India ETF (INDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs iShares MSCI India ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $590.53M), while iShares MSCI India ETF trades at $48.78. Which is the better fit depends on your goals.
| DNA | INDA | |
|---|---|---|
Market Cap | $590.53M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $16.14 | $55.29 |
52-Week Low | $5.48 | $45.42 |
Enterprise Value | $627.78M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.
The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.
INDA trades at $48.79, down 1.03% with a bearish technical signal from moving averages. The India ETF faces mixed sentiment as India's economy grows at 7.8% (CNBC, 2026-06-05) but confronts headwinds from IT sector weakness and Middle East risks. Technical indicators show neutral oscillators with key support at $48.
Outlook remains cautious amid valuation concerns and macroeconomic pressures. Investment opportunity lies in India's long-term growth story, but risks include foreign outflows, geopolitical tensions, and sector-specific challenges in technology and energy transition.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About iShares MSCI India ETF
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →
